(635) More Than 75% of Female Sexual Dysfunction Could Be Prevented and Depend on the Sexual Partner, but It’s Treatment Is the Problem

Abstract Introduction Sexual health affects both men and women, with a tremendous effect on the relationship. Premature Ejaculation (PE) and Female Sexual Dysfunction (FSD) are conditions characterized by difficulties that impact sexual health, self-esteem, body image, and partner relationships. Female Orgasmic Disorder (FOD) (the inability to reach orgasm in the presence of sexual stimulation) is under-diagnosed and has poor treatment options. The high prevalence of FSD, in addition to FOD prevalence, makes sexual partners an ideal target population for treatment. Objective The purpose of this study was to examine the high incidence of Female Orgasmic Disorder (FOD) secondary to the Male Sexual Dysfunction (MSD) or Premature Ejaculation (PE) of their partners. The aim was to shed light on the high incidence of FOD and the relationship between female orgasm and male response, emphasizing the negative impact of male and female sexual responses on the relationship. Methods The study was conducted by reviewing the charts of more than 5,000 women who completed the Female Sexual Distress Disorder (FSDD) and whose male partners had Male Sexual Dysfunction (MSD) or Premature Ejaculation (PE). The sample was restricted to women with a duration of male ejaculation. Classifications of PE were used, defining it as ejaculation that occurs or nearly always occurs in response to minimal sexual stimulation before, upon, or shortly after penile penetration, with the inability to meet the female partner's orgasm time. Demographic and clinical data were collected, including the duration of coital time needed for female sexual orgasm, using clinical observations and interviews with the couples. Results The review of more than 1,000 charts showed that 77.8% of female partners reported a sexual dysfunction. This was most commonly Female Orgasmic Disorder (FOD) secondary to the partner’s PE. Specifically, 75.4% of women seeking treatment for their male partner's MSD or PE had an Orgasmic Disorder (FOD) secondary to the PE. Furthermore, 70% of all women whose partners had PE reported an ejaculation time of less than 1 minute. Conclusions The study reports a high incidence of Female Orgasmic Disorder (FOD) secondary to PE or other MSD in the male partner, which appears to be the main problem in the treatment of PE. Despite the high incidence of FOD, the problem is still not fully recognized for the treatment of PE. Since treating male PE primarily affects ejaculation time, which is often insufficient for female orgasm, treatments must reevaluate definitions and address the female partner's sexual function, not just the male ejaculation time. This suggests that the female partner's sexual health is being overlooked, necessitating new protocols that integrate female sexual function as an essential part of sexual medicine. Disclosure No